Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer

Published:2018-01-15 Issue:1 Volume:16 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Zapała Piotr,Dybowski Bartosz,Poletajew Sławomir,Białek Łukasz,Niewczas Andrzej,Radziszewski Piotr

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s12957-018-1310-0.pdf

Reference30 articles.

1. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol. 2017;71(3):447–61.

2. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol. 1999;162(1):74–6.

3. Kassouf W, Aprikian A, Black P, Kulkarni G, Izawa J, Eapen L, et al. Recommendations for the improvement of bladder cancer quality of care in Canada: a consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015. Can Urol Assoc J J Assoc Urol Can. 2016;10(1–2):E46–80.

4. Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU Int. 2016;118(1):44–52.

5. Orsola A, Cecchini L, Raventós CX, Trilla E, Planas J, Landolfi S, et al. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR. BJU Int. 2010;105(2):202–7.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer;Proceedings of the National Academy of Sciences;2024-09-05

2. Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection;The French Journal of Urology;2024-09

3. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study;BMC Urology;2024-03-20

4. Progress of Multiparameter Magnetic Resonance Imaging in Bladder Cancer: A Comprehensive Literature Review;Diagnostics;2024-02-17

5. Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer;International Urology and Nephrology;2023-08-28